新辅助化疗治疗不能手术仅肝转移大肠癌32例
http://www.100md.com
孙宏劭, 封书德
新辅助化疗;大肠癌;肝转移;手术,孙宏劭,封书德,通讯作者:,Neoadjuvantchemotherapyforcolorectalcarcinomawithonlyhepaticmetastasis:ananalysisof32cases,Ho
 |
| 第1页 |
参见附件(710KB，3页)。
孙宏劭, 封书德, 武警江苏总队医院肿瘤内科 江苏省扬州市 225003
通讯作者: 孙宏劭, 225003, 江苏省扬州市运河西路272号, 武警江苏总队医院肿瘤内科. yzwjyhm@sohu.com
电话: 0514-7232421-33107
收稿日期: 2006-09-30 接受日期: 2006-10-18
Neoadjuvant chemotherapy for colorectal carcinoma with only hepatic metastasis: an analysis of 32 cases
Hong-Shao Sun, Shu-De Feng
Hong-Shao Sun, Shu-De Feng,Department of Internal Oncology, General Hospital of Jiangsu Armed Police, Yangzhou 225003, Jiangsu Province, China
Correspondence to:Hong-Shao Sun, Department of Internal Oncology, General Hospital of Jiangsu Armed Police, 272 Yunhe West Road, Yangzhou 225003, Jiangsu Province, China. yzwjyhm@sohu.com
Received:2006-09-30 Accepted:2006-10-18
Abstract
AIM: To confirm whether neoadjuvant chemotherapy (NACT) can provide surgical treatment opportunities for colorectal carcinoma patients with only liver metastasis.
METHODS: A total of 32 colorectal carcinoma patients with liver metastasis, who could not receive surgical therapy, were treated with NACT, and then the efficacy was analyzed. The survival time was compared between patients received operation after NACT treatment and those who didn’t receive.
RESULTS: The efficacy rate of NACT was 56%, and the surgical resection rate was 34%. Complete resection was achieved in 10 cases. The survival time was significantly different between the patients received operation after NACT treatment and those who didn’t receive (P < 0.05).
CONCLUSION: NACT can provide opportunities for colorectal carcinoma patients with only liver metastasis, who can’t receive surgical treatment ......
您现在查看是摘要介绍页，详见PDF附件(710KB，3页)。